The Hypothalamus-pituitary-adrenocortical Response to Critical Illness: A Concept in Need of Revision.

IF 22 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM Endocrine reviews Pub Date : 2023-11-09 DOI:10.1210/endrev/bnad021
Lies Langouche, Arno Téblick, Jan Gunst, Greet Van den Berghe
{"title":"The Hypothalamus-pituitary-adrenocortical Response to Critical Illness: A Concept in Need of Revision.","authors":"Lies Langouche, Arno Téblick, Jan Gunst, Greet Van den Berghe","doi":"10.1210/endrev/bnad021","DOIUrl":null,"url":null,"abstract":"<p><p>Based on insights obtained during the past decade, the classical concept of an activated hypothalamus-pituitary-adrenocortical axis in response to critical illness is in need of revision. After a brief central hypothalamus-pituitary-adrenocortical axis activation, the vital maintenance of increased systemic cortisol availability and action in response to critical illness is predominantly driven by peripheral adaptations rather than by an ongoing centrally activated several-fold increased production and secretion of cortisol. Besides the known reduction of cortisol-binding proteins that increases free cortisol, these peripheral responses comprise suppressed cortisol metabolism in liver and kidney, prolonging cortisol half-life, and local alterations in expression of 11βHSD1, glucocorticoid receptor-α (GRα), and FK506 binding protein 5 (FKBP51) that appear to titrate increased GRα action in vital organs and tissues while reducing GRα action in neutrophils, possibly preventing immune-suppressive off-target effects of increased systemic cortisol availability. Peripherally increased cortisol exerts negative feed-back inhibition at the pituitary level impairing processing of pro-opiomelanocortin into ACTH, thereby reducing ACTH-driven cortisol secretion, whereas ongoing central activation results in increased circulating pro-opiomelanocortin. These alterations seem adaptive and beneficial for the host in the short term. However, as a consequence, patients with prolonged critical illness who require intensive care for weeks or longer may develop a form of central adrenal insufficiency. The new findings supersede earlier concepts such as \"relative,\" as opposed to \"absolute,\" adrenal insufficiency and generalized systemic glucocorticoid resistance in the critically ill. The findings also question the scientific basis for broad implementation of stress dose hydrocortisone treatment of patients suffering from acute septic shock solely based on assumption of cortisol insufficiency.</p>","PeriodicalId":11544,"journal":{"name":"Endocrine reviews","volume":" ","pages":"1096-1106"},"PeriodicalIF":22.0000,"publicationDate":"2023-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638597/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/endrev/bnad021","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Based on insights obtained during the past decade, the classical concept of an activated hypothalamus-pituitary-adrenocortical axis in response to critical illness is in need of revision. After a brief central hypothalamus-pituitary-adrenocortical axis activation, the vital maintenance of increased systemic cortisol availability and action in response to critical illness is predominantly driven by peripheral adaptations rather than by an ongoing centrally activated several-fold increased production and secretion of cortisol. Besides the known reduction of cortisol-binding proteins that increases free cortisol, these peripheral responses comprise suppressed cortisol metabolism in liver and kidney, prolonging cortisol half-life, and local alterations in expression of 11βHSD1, glucocorticoid receptor-α (GRα), and FK506 binding protein 5 (FKBP51) that appear to titrate increased GRα action in vital organs and tissues while reducing GRα action in neutrophils, possibly preventing immune-suppressive off-target effects of increased systemic cortisol availability. Peripherally increased cortisol exerts negative feed-back inhibition at the pituitary level impairing processing of pro-opiomelanocortin into ACTH, thereby reducing ACTH-driven cortisol secretion, whereas ongoing central activation results in increased circulating pro-opiomelanocortin. These alterations seem adaptive and beneficial for the host in the short term. However, as a consequence, patients with prolonged critical illness who require intensive care for weeks or longer may develop a form of central adrenal insufficiency. The new findings supersede earlier concepts such as "relative," as opposed to "absolute," adrenal insufficiency and generalized systemic glucocorticoid resistance in the critically ill. The findings also question the scientific basis for broad implementation of stress dose hydrocortisone treatment of patients suffering from acute septic shock solely based on assumption of cortisol insufficiency.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
下丘脑-垂体-肾上腺皮质对危重疾病的反应:一个需要修正的概念。
基于过去十年获得的见解,对危重疾病反应的激活下丘脑-垂体-肾上腺皮质轴的经典概念需要修订。在短暂的中枢下丘脑-垂体-肾上腺皮质轴激活后,增加的全身皮质醇可用性和对危重疾病的反应的重要维持主要是由外周适应驱动的,而不是由持续的中央激活的几倍增加的皮质醇的产生和分泌驱动的。除了已知的增加游离皮质醇的皮质醇结合蛋白的减少外,这些外周反应还包括肝脏和肾脏中皮质醇代谢的抑制,皮质醇半衰期的延长,以及11βHSD1、糖皮质激素受体-α (GRα)和FK506结合蛋白5 (FKBP51)表达的局部改变,这些表达似乎会增加重要器官和组织中GRα的作用,同时降低中性粒细胞中GRα的作用。可能防止免疫抑制脱靶效应增加全身皮质醇可用性。外周升高的皮质醇在垂体水平上产生负反馈抑制,损害促肾上腺皮质激素的加工过程,从而减少促肾上腺皮质激素驱动的皮质醇分泌,而持续的中枢激活导致循环促肾上腺皮质激素的增加。这些变化似乎是适应性的,在短期内对宿主有益。然而,结果是,需要重症监护数周或更长时间的重症患者可能会出现中枢性肾上腺功能不全。新发现取代了早期的概念,如“相对”,而不是“绝对”,肾上腺功能不全和危重患者全身糖皮质激素抵抗。研究结果还质疑了仅仅基于皮质醇不足假设而广泛实施应激剂量氢化可的松治疗急性感染性休克患者的科学依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Endocrine reviews
Endocrine reviews 医学-内分泌学与代谢
CiteScore
42.00
自引率
1.00%
发文量
29
期刊介绍: Endocrine Reviews, published bimonthly, features concise timely reviews updating key mechanistic and clinical concepts, alongside comprehensive, authoritative articles covering both experimental and clinical endocrinology themes. The journal considers topics informing clinical practice based on emerging and established evidence from clinical research. It also reviews advances in endocrine science stemming from studies in cell biology, immunology, pharmacology, genetics, molecular biology, neuroscience, reproductive medicine, and pediatric endocrinology.
期刊最新文献
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status. Teprotumumab for the Treatment of Thyroid Eye Disease. Common and Uncommon Mouse Models of Growth Hormone Deficiency. Risks of Iodine Excess. Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1